CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease

Viral Immunology

Volumn 20, Issue 1, 2007, Pages 19-33

  Bennett, Jami L ^a   Elhofy, Adam ^a   Charo, Israel ^b   Miller, Stephen D ^a   Dal Canto, Mauro C ^a   Karpus, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR2; GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN; PROTEOLIPID PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; INTERFERON PRODUCTION; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE CELL LESION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; VIRUS TITRATION;

ANIMALS; BRAIN; CARDIOVIRUS INFECTIONS; DEMYELINATING DISEASES; INTERFERON TYPE II; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CHEMOKINE; THEILOVIRUS; VIRAL LOAD;

MURINAE; MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 34247263341     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.0068     Document Type: Article

References (54)

1. Asensio VC, Maier J, Milner R, Boztug K, Kincaid C, Moulard M, Phillipson C, Lindsley K, Krucker T, Fox HS, and Campbell IL: Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol 2001;75:7067-7077.
2. Belnoue E, Costa FT, Vigario AM, Voza T, Gonnet F, Landau I, Van Rooijen N, Mack M, Kuziel WA, and Renia L: Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun 2003;71:3648-3651.
3. + monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neurovirol 2003;9:623-636.
4. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RVJ, Broxmeyer HE, and Charo IF: Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-2561.
5. Brahic M, Stroop WG, and Baringer JR: Theiler's virus persists in glial cells during demyelinating disease. Cell 198;26:123-128.
6. Brodmerkel CM, Huber R, Covington M, Diamond S, Hall L, Collins R, Leffet L, Gallagher K, Feldman P, Collier P, Stow M, Gu X, Baribaud F, Shin N, Thomas B, Burn T, Hollis G, Yeleswaram S, Solomon K, Friedman S, Wang A, Xue CB, Newton RC, Scherle P, and Vaddi K: Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol 2005;175:5370-5378.
7. Brosnan CF, Bornstein MB, and Bloom BR: The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 1981;126:614-620.
8. + T cells. J Immunol 2004;172:890-898.
9. Chen BP, Kuziel WA, and Lane TE: Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 2001;167:4585-4592.
10. Clatch RJ, Lipton HL, and Miller SD: Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J Immunol 1986;136:920-927.
11. Clatch RJ, Lipton HL, and Miller SD: Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb Pathog 1987;3:327-337.
12. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, and Lipton HL: Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 1990;176: 244-254.
13. Dal Canto MC, and Lipton HL: Primary demyelination in Theiler's virus infection: An ultrastructural study. Lab Invest 1975;33:626-637.
14. Fife BT, Huffnagle GB, Kuziel WA, and Karpus WJ: CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 2000;192: 899-906.
15. Gerety SJ, Karpus WJ, Cubbon AR, Goswami RG, Rundell MK, Peterson JD, and Miller SD: Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J Immunol 1994;152:908-918.
16. Hoffman LM, Fife BT, Begolka WS, Miller SD, and Karpus WJ: Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J Neurovirol 1999;5:635-642.
17. Huitinga I, Van Rooijen N, de Groot CJ, Uitdehaag BM, and Dijkstra CD: Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990;172:1025-1033.
18. Izikson L, Klein RS, Charo IF, Weiner HL, and Luster AD: Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000;192:1075-1080.
19. Jarousse N, Syan S, Martinat C, and Brahic M: The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability to infect cultured neurons. J Virol 1998;72:7213-7220.
20. Jelachich ML, and Lipton HL: Restricted Theiler's murine encephalomyelitis virus infection in murine macrophages induces apoptosis. J Gen Virol 1999;80:1701-1705.
21. Karpus WJ, Kennedy KJ, Fife BT, Dal Canto MC, Kunkel SL, and Lukacs NW: Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neurovirol 2006;12:251-261.
22. Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, and Miller SD: Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 1999;104:599-610.
23. Kurihara T, and Bravo R: Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J Biol Chem 1996;271:11603-11607.
24. Kurihara T, Warr G, Loy J, and Bravo R: Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997;186: 1757-1762.
25. Kurtz CI, Sun XM, and Fujinami RS: B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J Virol 1995;69:5152-5155.
26. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, and Buchmeier MJ: Dynamic regulation of α- and β-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998;160:970-978.
27. Lipton HL: Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect Immun 1975;11:1147-1155.
28. Lipton HL, and Gonzalez-Scarano F: Central nervous system immunity in mice infected with Theiler's virus. I. Local neutralizing antibody response. J Infect Dis 1978;137: 145-151.
29. Lipton HL, Twaddle G, and Jelachich ML: The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 1995;69:2525-2533.
30. Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachy J, Bruhl H, Frink M, Anders HJ, Vielhauer V, Pfirstinger J, Stangassinger M, and Schlondorff D: Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol 2001;166: 4697-4704.
31. Miller SD, Karpus WJ, Pope JG, Dal Canto MC, and Melvold RW: Theiler's virus-induced demyelinating disease. In: Autoimmune Disease Models: A Guidebook (Cohen IR, and Miller A, eds.). Academic Press, New York, 1994.
32. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, and Kim BS: Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3: 1133-1136.
33. Moser B, Wolf M, Walz A, and Loetscher P: Chemokines: Multiple levels of leukocyte migration control. Trends Immunol 2004;25:75-84.
34. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, and Power CA: International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52: 145-176.
35. Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, and Rodriguez M: Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis. J Neurovirol 2000;6(Suppl 1):S44-S52.
36. + T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol 1998;72:7320-7329.
37. + T cells increase during viral infection and migrate to sites of infection. Eur J Immunol 2000;30:1797-1806.
38. Oehen S, and Brduscha-Riem K: Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J Immunol 1998;161:5338-5346.
39. Oleszak EL, Katsetos CD, Kuzmak J, and Varadhachary A: Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection. J Virol 1997;71: 3228-3235.
40. Palma JP, and Kim BS: Induction of selected chemokines in glial cells infected with Theiler's virus. J Neuroimmunol 2001;117:166-170.
41. Pavelko KD, Howe CL, Drescher KM, Gamez JD, Johnson AJ, Wei T, Ransohoff RM, and Rodriguez M: Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J Neurosci 2003;23:481-492.
42. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, and Ernst JD: Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2001;98:7958-7963.
43. Peterson KE, Errett JS, Wei T, Dimcheff DE, Ransohoff R, Kuziel WA, Evans L, and Chesebro B: MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: Role for astrocytes in retroviral neuropathogenesis. J Virol 2004;78:6449-6458.
44. Pistorio AL, Hendry SH, and Wang X: A modified technique for high-resolution staining of myelin. J Neurosci Methods 2006;153:135-146.
45. + T cell-mediated pathology. J Immunol 1996;156:4050-4058.
46. Rossi CP, Delcroix M, Huitinga I, McAllister A, Van Rooijen N, Claasen E, and Brahic M: Role of macrophages during Theiler's virus infection. J Virol 1997;71:3336-3340.
47. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, and Ahuja SS: CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 2000;192:205-218.
48. Schlaf G, Salje C, Wetter A, Stuertz K, Felgenhauer K, and Mader M: Determination of synapsin I and synaptophysin in body fluids by two-site enzyme-linked immunosorbent assays. J Immunol Methods 1998;213:191-199.
49. Theil DJ, Tsunoda I, Libbey JE, Derfuss TJ, and Fujinami RS: Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J Neuroimmunol 2000;104:22-30.
50. Traynor TR, Kuziel WA, Toews GB, and Huffnagle GB: CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 2000;164:2021-2027.
51. Trottier M, Schlitt BP, and Lipton HL: Enhanced detection of Theiler's virus RNA copy equivalents in the mouse central nervous system by real-time RT-PCR. J Virol Methods 2002;103:89-99.
52. Zheng L, Calenoff MA, and Dal Canto MC: Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol 2001;118: 256-267.
53. Zhu B, Luo L, Moore GR, Paty DW, and Cynader MS: Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol 2003;162: 1639-1650.
54. Zlotnik A, and Yoshie O: Chemokines: A new classification system and their role in immunity. Immunity 2000;12: 121-127.